NCT02042482View on ClinicalTrials.gov

The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Myelodysplastic Syndrome
Interventions
DIETARY_SUPPLEMENT

Coenzyme Q10U, L-carnitine

Trial Locations (1)

76100

RECRUITING

Kaplan Medical Center, Rehovot

Sponsors
All Listed Sponsors
collaborator

Weizmann Institute of Science

OTHER

lead

Kaplan Medical Center

OTHER